ストックスクリーナーアプリを入手
19.22
2.37%
0.45
前日終値:
$18.77
開ける：
$18.52
24時間の取引高:
64,944
Relative Volume:
0.37
時価総額：
$673.25M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.81%
1か月 パフォーマンス:
-17.32%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$18.52
$19.25
1週間の範囲:
$18.50
$19.95
52週間の値動き範囲:
$18.50
$32.75
Ceribell Inc Stock (CBLL) Company Profile
CBLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
19.24 | 673.25M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
131.69 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.03 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
376.99 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.67 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.78 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | 開始されました | BofA Securities | Buy |
| 2024-11-05 | 開始されました | Canaccord Genuity | Buy |
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | 開始されました | William Blair | Outperform |
Ceribell Inc (CBLL) 最新ニュース
CeriBell’s (NASDAQ:CBLL) Lock-Up Period To Expire on April 9th - Defense World
Critical Comparison: CeriBell (NASDAQ:CBLL) and InMode (NASDAQ:INMD) - Defense World
Charles Schwab Investment Management Inc. Invests $2.50 Million in CeriBell (NASDAQ:CBLL) - Defense World
Bank of New York Mellon Corp Purchases New Holdings in CeriBell (NASDAQ:CBLL) - Defense World
PNC Financial Services Group Inc. Invests $47,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell, Inc. Announces Executive Compensation Adjustments - TipRanks
Ceribell executives receive pay increases and incentives By Investing.com - Investing.com Australia
Ceribell executives receive pay increases and incentives - Investing.com
Brokerages Set CeriBell (NASDAQ:CBLL) Price Target at $32.60 - MarketBeat
CeriBell (NASDAQ:CBLL) Receives $32.60 Average PT from Analysts - Defense World
Rhumbline Advisers Makes New Investment in CeriBell (NASDAQ:CBLL) - Defense World
CeriBell’s Earnings Call: Strong Growth Amid Challenges - TipRanks
William Blair Has Negative Estimate for CeriBell Q1 Earnings - Armenian Reporter
William Blair Estimates CeriBell’s Q1 Earnings (NASDAQ:CBLL) - Defense World
Canaccord Genuity Group Reaffirms Buy Rating for CeriBell (NASDAQ:CBLL) - Defense World
Ceribell revenue increases 41% to USD 18.5M in Q4 2024 - Medical Buyer
CeriBell, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com
Ceribell, Inc.: Strong Financial Performance and Strategic Investments Justify Buy Rating - TipRanks
Strong Financial Performance and Strategic Growth Initiatives Drive Buy Rating for Ceribell, Inc. - TipRanks
Ceribell, Inc. Reports Strong 2024 Financial Growth - TipRanks
Ceribell, Inc.: Strong Financial Performance and Growth Potential Drive Buy Rating - TipRanks
Earnings call transcript: CeriBell Q4 2024 shows 41% revenue growth - Investing.com
Earnings call transcript: CeriBell Q4 2024 shows 41% revenue growth By Investing.com - Investing.com UK
CeriBell Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Ceribell, Inc. Reports Significant Revenue Growth in Fourth Quarter and Full Year 2024 Financial Results - Nasdaq
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
CeriBell Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
CeriBell: A Leader In AI-Powered Seizure Detection (NASDAQ:CBLL) - Seeking Alpha
CeriBell (CBLL) to Release Earnings on Tuesday - MarketBeat
Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference - GlobeNewswire
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Target Price from Analysts - MarketBeat
CeriBell (NASDAQ:CBLL) Receives $32.60 Average Price Target from Brokerages - Defense World
Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewswire
CeriBell, Inc. to Announce Q4 and Full Year 2024 Financial Results on February 25, 2025 - Nasdaq
CeriBell (CBLL) Expected to Announce Quarterly Earnings on Tuesday - Defense World
CeriBell (CBLL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Hospitals adopt AI tech to improve seizure detection in Humboldt County - KRCR
Nexalin Technology (NASDAQ:NXL) vs. CeriBell (NASDAQ:CBLL) Head-To-Head Contrast - Defense World
CeriBell (NASDAQ:CBLL) Trading 9.1% HigherShould You Buy? - MarketBeat
Beta Bionics targets up to $616 mln valuation in US IPO - Reuters
CeriBell (NASDAQ:CBLL) Receives $32.60 Consensus Price Target from Analysts - Defense World
Ceribell Expands its Executive Management Team by Two - MPO-mag
CeriBell (NASDAQ:CBLL) Hits New 52-Week LowTime to Sell? - MarketBeat
CeriBell (NASDAQ:CBLL) Shares Down 9.2%Should You Sell? - MarketBeat
CeriBell (NASDAQ:CBLL) Trading Down 3.3%What's Next? - MarketBeat
Ceribell Inc (CBLL) 財務データ
Ceribell Inc (CBLL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Ceribell Inc (CBLL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 10% Owner |
Oct 15 '24 |
Buy |
17.00 |
380,268 |
6,464,556 |
3,967,422 |
| Tammenoms Bakker Juliet | Director |
Oct 15 '24 |
Buy |
17.00 |
237,234 |
4,032,978 |
2,475,110 |
0.44%
0.15%
大文字化:
|
ボリューム (24 時間):